South San Francisco, California, 15 September, 2006 - Napo Pharmaceuticals, Inc., (LSE: NAPL), which focuses on bringing proprietary products to the global marketplace in collaboration with local partners, today announces its interim results for the six months ended 30 June 2006. The Company listed its shares on the Main Market of the London Stock Exchange in July 2006.
